Skip to main navigation Skip to main content Skip to page footer

Clinical information

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease belonging to the group of connective tissue diseases. The classification criteria of the  European Alliance of Associations for Rheumatology (EULAR) and the American College of Rheumatology (ACR), revised in 2019, contain 7 clinical and 3 immunological categories, with each parameter weighted using a point system. A case is classified as SLE if the entry criterion of a positive ANA test is fulfilled and the total score is at least 10.

Antibodies against double-stranded DNA (dsDNA) are the main focus of serological SLE diagnostics. These antibodies can be found in 60 % to 90 % of patients, depending on the activity of the disease. In rare cases, anti-dsDNA antibodies are also found in patients with other autoimmune diseases (e. g. autoimmune hepatitis) or infections and in clinically healthy persons. 85 % of people in the latter group develop SLE within 5 years of initial detection of anti-dsDNA. However, SLE cannot be excluded if anti-dsDNA antibodies are not detected.

Antibodies against nucleosomes are also an exclusive marker of SLE, provided that they are determined using a test system with a target antigen that is free of histone H1, Scl-70 and other non-histone proteins.

Anti-Sm antibodies are also highly specific markers but  much rarer. Anti-Sm and anti-dsDNA antibodies each have a high weighting of 6 points in the classification criteria.

Diagnostics

Various test methods are available for the routine detection of antibodies against dsDNA: enzyme immunotests, such as ELISA or EUROLINE, and the Crithidia luciliae immunofluorescence test (CLIFT) The test systems differ, sometimes greatly, regarding their sensitivity and specificity. The conventional CLIFT, for example, shows a particularly high disease specificity, while the IIFT Crithidia luciliae sensitive was developed with a focus on high sensitivity. 

Thanks to the use of highly purified nucleosomes as linking substance, the performance data of the Anti-dsDNA-NcX ELISA are significantly higher than those of conventional anti-dsDNA ELISAs. Because of their strong adhesive ability, even a very low concentration of these nucleosomes is suited to coupling isolated dsDNA to the surface of a microplate well. False positive reactions due to conventional linking substances such as poly-L lysine and protamine sulphate are avoided.

In a clinical comparative study of 564 patients with rheumatic diseases (of these 207 with SLE), the Anti-dsDNA-NcX ELISA yielded an 8 % higher sensitivity than the Anti-dsDNA RIA (Biesen et al., Arthritis Res Ther (2011) 13:R26). Nevertheless, different test methods identify different SLE subgroups, so different test systems should be combined to increase the serological detection rate.

Methods
Technology Parameter Substrate Species Calibration Ig Class Format Order No.
IIFT cell nuclei (ANA) HEp-2 cells
(1 BIOCHIP per field)
human IgG
IgG
IgG
IgG
10 x 50
120 x 10
20 x 05
20 x 10
FA 1520-1050-R
FA 1520-12010-R
FA 1520-2005-R
FA 1520-2010-R
IIFT cell nuclei (ANA) HEp-20-10 cells
(1 BIOCHIP per field)
human IgG
IgG
IgG
IgG
10 x 50
120 x 10
20 x 05
20 x 10
FA 1522-1050-R
FA 1522-12010-R
FA 1522-2005-R
FA 1522-2010-R
ChLIA IDS SS-A/Ro 52 kDa antigenic coated magnetic particles SS-A/Ro 52 kDa quantitative
50 x 01
IS-AI11031
IIFT antibodies against cell nuclei
(ANA control), homogeneous pattern
IgG 05 x 02
CA 1570-0502
IIFT antibodies against dsDNA
(dsDNA ab control)
IgG 05 x 02
CA 1572-0502
IIFT cell nuclei
(ANA global test)
HEp-2 cells
liver
(2 BIOCHIPs per field)
human
monkey
IgG
IgG
IgG
IgG
IgG
IgG
IgG
10 x 05
10 x 10
10 x 50
120 x 10
20 x 05
20 x 10
24 x 50
10 x 05
10 x 10
10 x 50
20 x 05
20 x 10
FA 1510-1005-1
FA 1510-1010-1
FA 1510-1050-1
FA 1510-12010-1
FA 1510-2005-1
FA 1510-2010-1
FA 1510-2450-1
FB 1510-1005-1
FB 1510-1010-1
FB 1510-1050-1
FB 1510-2005-1
FB 1510-2010-1
IIFT cell nuclei (ANA)
mitochondria (AMA)
HEp-2 cells
kidney
(2 BIOCHIPs per field)
human
rat
IgG
IgG
10 x 05
10 x 10
10 x 05
10 x 10
FA 1510-1005-2
FA 1510-1010-2
FB 1510-1005-2
FB 1510-1010-2
IIFT cell nuclei
(ANA global test)
HEp-20-10 cells
liver
(2 BIOCHIPs per field)
human
monkey
IgG
IgG
IgG
IgG
IgG
IgG
IgG
10 x 05
10 x 10
10 x 50
120 x 10
20 x 05
20 x 10
24 x 50
10 x 05
10 x 10
10 x 50
20 x 05
20 x 10
FA 1512-1005-1
FA 1512-1010-1
FA 1512-1050-1
FA 1512-12010-1
FA 1512-2005-1
FA 1512-2010-1
FA 1512-2450-1
FB 1512-1005-1
FB 1512-1010-1
FB 1512-1050-1
FB 1512-2005-1
FB 1512-2010-1
IIFT cell nuclei (ANA)
mitochondria (AMA)
HEp-20-10 cells
kidney
(2 BIOCHIPs per field)
human
rat
IgG
IgG
IgG
10 x 05
10 x 10
10 x 50
10 x 05
10 x 10
10 x 50
FA 1512-1005-2
FA 1512-1010-2
FA 1512-1050-2
FB 1512-1005-2
FB 1512-1010-2
FB 1512-1050-2
IIFT cell nuclei (ANA) HEp-2 cells human IgG
IgG
IgG
IgG
IgG
IgG
10 x 05
10 x 10
10 x 50
120 x 10
20 x 05
20 x 10
10 x 05
10 x 10
10 x 50
20 x 05
20 x 10
FA 1520-1005
FA 1520-1010
FA 1520-1050
FA 1520-12010
FA 1520-2005
FA 1520-2010
FB 1520-1005
FB 1520-1010
FB 1520-1050
FB 1520-2005
FB 1520-2010
IIFT cell nuclei (ANA) HEp-20-10 cells human IgG
IgG
IgG
IgG
10 x 05
10 x 10
20 x 05
20 x 10
10 x 05
10 x 10
20 x 05
20 x 10
FA 1522-1005
FA 1522-1010
FA 1522-2005
FA 1522-2010
FB 1522-1005
FB 1522-1010
FB 1522-2005
FB 1522-2010
IIFT dsDNA flagellates Crithidia luciliae IgG
IgG
IgG
IgG
10 x 05
10 x 10
20 x 05
20 x 10
10 x 05
10 x 10
20 x 05
20 x 10
FA 1572-1005
FA 1572-1010
FA 1572-2005
FA 1572-2010
FB 1572-1005
FB 1572-1010
FB 1572-2005
FB 1572-2010
IIFT dsDNA (sensitive) flagellates Crithidia luciliae IgG
IgG
IgG
IgG
10 x 05
10 x 10
20 x 05
20 x 10
FA 1572-1005-1
FA 1572-1010-1
FA 1572-2005-1
FA 1572-2010-1
IIFT cell nuclei (ANA) EUROPattern
cell nuclei (ANA)
HEp-2 cells
liver
(2 BIOCHIPs per field)
human
monkey
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
10 x 05
10 x 10
120 x 10
20 x 05
20 x 10
24 x 50
10 x 50
20 x 10
FC 1510-1005-1
FC 1510-1010-1
FC 1510-12010-1
FC 1510-2005-1
FC 1510-2010-1
FC 1510-2450-1
FW 1510-1050-1
FW 1510-2010-1
IIFT cell nuclei (ANA) EUROPattern
cell nuclei (ANA)
HEp-20-10 cells
liver
(2 BIOCHIPs per field)
human
monkey
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
10 x 05
10 x 10
10 x 50
120 x 10
20 x 05
20 x 10
24 x 50
10 x 05
10 x 10
10 x 50
20 x 10
FC 1512-1005-1
FC 1512-1010-1
FC 1512-1050-1
FC 1512-12010-1
FC 1512-2005-1
FC 1512-2010-1
FC 1512-2450-1
FW 1512-1005-1
FW 1512-1010-1
FW 1512-1050-1
FW 1512-2010-1
IIFT cell nuclei (ANA) EUROPattern
mitochondria (AMA)
HEp-20-10 cells
kidney
(2 BIOCHIPs per field)
human
rat
IgG PI
IgG PI
IgG PI
10 x 05
120 x 10
FC 1512-1005-2
FC 1512-12010-2
FC 1512-2450-2
IIFT cell nuclei (ANA)
EUROPattern
HEp-2 cells human IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
10 x 05
10 x 10
10 x 50
120 x 10
20 x 05
20 x 10
24 x 50
10 x 05
10 x 10
10 x 50
20 x 05
20 x 10
FC 1520-1005
FC 1520-1010
FC 1520-1050
FC 1520-12010
FC 1520-2005
FC 1520-2010
FC 1520-2450
FW 1520-1005
FW 1520-1010
FW 1520-1050
FW 1520-2005
FW 1520-2010
IIFT cell nuclei (ANA)
EUROPattern
HEp-20-10 cells human IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
IgG PI
10 x 05
10 x 10
10 x 50
120 x 10
20 x 05
20 x 10
10 x 05
20 x 05
20 x 10
FC 1522-1005
FC 1522-1010
FC 1522-1050
FC 1522-12010
FC 1522-2005
FC 1522-2010
FW 1522-1005
FW 1522-2005
FW 1522-2010
IIFT dsDNA
EUROPattern
flagellates Crithidia luciliae IgG EB
IgG EB
IgG EB
IgG EB
10 x 05
10 x 10
20 x 05
20 x 10
FC 1572-1005
FC 1572-1010
FC 1572-2005
FC 1572-2010
IIFT dsDNA (sensitive)
EUROPattern
flagellates Crithidia luciliae IgG EB
IgG EB
IgG EB
IgG EB
IgG EB
10 x 05
10 x 10
120 x 10
20 x 05
20 x 10
FC 1572-1005-1
FC 1572-1010-1
FC 1572-12010-1
FC 1572-2005-1
FC 1572-2010-1
ELISA Anti-Histones ELISA (IgG) antigen-coated
microplate wells
native, highly purified histones,
bovine thymus
2/20/200 RU/ml IgG 96 x 01
EA 1560-9601 G
ELISA Anti-dsDNA ELISA (IgG)
double-stranded DNA
antigen-coated
microplate wells
highly purified genomic
double-stranded DNA
10/100/800 IU/ml IgG 96 x 01
EA 1571-9601 G
ELISA Anti-dsDNA-NcX ELISA (IgG) antigen-coated
microplate wells
highly purified genomic
double-stranded DNA,
complexed with nucleosomes
10/100/800 IU/ml IgG 96 x 01
EA 1572-9601 G
ELISA Anti-Nucleosomes ELISA (IgG) antigen-coated
microplate wells
native, nucleosomes,
calf thymus
2/20/200 RU/ml IgG 96 x 01
EA 1574-9601 G
ELISA Anti-ENA SLE Profile 2-ELISA (IgG)
(dsDNA, histones, nucleosomes, nRNP/Sm, Sm,
SS-A, SS-B, Scl-70 separately)
antigen-coated
microplate wells
see individual ELISA semi-quantitative IgG 12 x 08
EA 1590-1208-12 G
ELISA Anti-ENA ProfilePlus 2 ELISA (IgG)
(ribosomal P-proteins, nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1, centromeres, separately)
antigen-coated
microplate wells
see individual ELISA semi-quantitative IgG 12 x 08
EA 1590-1208-2 G
ELISA ANA Screen 11 ELISA (IgG)
(antigen mixture: PCNA, PM-Scl, ribosomal P-proteins, nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, Jo-1, centromeres)
antigen-coated
microplate wells
see individual ELISA semi-quantitative IgG 96 x 01
EA 1590-9601-11 G
ELISA ANA Screen 9 ELISA (IgG)
(antigen mixture: PCNA, PM-Scl, ribosomal P-proteins, nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1)
antigen-coated
microplate wells
see individual ELISA semi-quantitative IgG 96 x 01
EA 1590-9601-14 G
ELISA ANA Screen ELISA (IgG)
(antigen mixture: dsDNA, histones, ribosomal P-proteins, nRNP/Sm, Sm, SS-A, SS-B, Scl-70, Jo-1, centromeres)
antigen-coated
microplate wells
see individual ELISA semi-quantitative IgG 96 x 01
EA 1590-9601-8 G
ELISA Anti-ENA Pool ELISA (IgG)
(antigen mixture: nRNP/Sm, Sm, SS-A, SS-B, Scl-70, ribosomal P-proteins, Ro-52)
antigen-coated
microplate wells
see individual ELISA semi-quantitative IgG 96 x 01
EA 1590-9601-9 G
ELISA Anti-Sm ELISA (IgG) antigen-coated
microplate wells
native, U2-, U4-, U5-, U6-nRNP, incl. B, B',
D, E, F, G, calf thymus
2/20/200 RU/ml IgG 96 x 01
EA 1593-9601 G
EUROLINE EUROLINE ANA Profile 23 (IgG)
(nucleosomes, dsDNA, histones, SS-A, Ro-52,
SS-B, nRNP/Sm, Sm, Mi-2 alpha, Mi-2 beta, Ku, CENP A,
CENP B, Sp100, PML, Scl-70, PM-Scl100, PM-Scl75,
RP11, RP155, gp210, PCNA, DFS70 separately)
EUROLINE IgG
IgG
IgG
16 x 01
50 x 01
64 x 01
DL 1590-1601-23 G
DL 1590-5001-23 G
DL 1590-6401-23 G
EUROLINE EUROLINE ANA Profile 3 (IgG)
(nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl,
Jo-1, CENP B, PCNA, dsDNA, nucleosomes,
histones, ribosomal P-proteins, AMA M2 separately)
EUROLINE IgG
IgG
IgG
16 x 01
50 x 01
64 x 01
DL 1590-1601-3 G
DL 1590-5001-3 G
DL 1590-6401-3 G
EUROLINE EUROLINE ANA Profile 3 plus DFS70 (IgG)
(nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl,
Jo-1, CENP B, PCNA, dsDNA, nucleosomes, histones,
ribosomal P-proteins, AMA M2, DFS70 separately)
EUROLINE IgG
IgG
IgG
16 x 01
50 x 01
64 x 01
DL 1590-1601-30 G
DL 1590-5001-30 G
DL 1590-6401-30 G
EUROLINE EUROLINE ANA Profile et Mi-2 et Ku (IgG)
(Mi-2, Ku, nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70,
PM-Scl, Jo-1, CENP B, PCNA, dsDNA, nucleosomes,
histones, ribosomal P-proteins, AMA M2 separately)
EUROLINE IgG
IgG
16 x 01
64 x 01
DL 1590-1601-31 G
DL 1590-6401-31 G
EUROLINE EUROLINE ANA Profile et Mi-2, Ku, DFS70 (IgG)
(Mi-2, Ku, nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70,
PM-Scl100, Jo-1, CENP B, PCNA, dsDNA,
nucleosomes, histones, ribosomal P-proteins,
AMA M2, DFS70 separately)
EUROLINE IgG
IgG
IgG
16 x 01
50 x 01
64 x 01
DL 1590-1601-33 G
DL 1590-5001-33 G
DL 1590-6401-33 G
EUROLINE EUROLINE ANA Profile 5 (IgG)
(nRNP/Sm, Sm, RNP70, RNPA, RNPC, SS-A,
Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B,
PCNA, dsDNA, nucleosomes, histones,
ribosomal P-proteins, AMA M2 separately)
EUROLINE IgG
IgG
16 x 01
64 x 01
DL 1590-1601-5 G
DL 1590-6401-5 G
EUROLINE EUROLINE ANA-Profile 1 (IgG)
(nRNP/Sm, Sm, SS-A, Ro-52, SS-B, Scl-70,
Jo-1, CENP B, dsDNA, nucleosomes, histones,
ribosomal P-proteins separately)
EUROLINE IgG
IgG
IgG
16 x 01
50 x 01
64 x 01
DL 1590-1601-8 G
DL 1590-5001-8 G
DL 1590-6401-8 G
ChLIA IDS ANA Screen antigenic coated magnetic particles dsDNA, Centromere B, SS-A/Ro (60 kDa and 52 kDa), SS-B/La, Sm, U1-snRNP (70 kDa, A and C), Scl-70, Jo-1 qualitative
100 x 01
IS-AI10011
ChLIA IDS ENA Screen antigenic coated magnetic particles SS-A/Ro (60 kDa and 52 kDa), SS-B/La, Sm, U1-snRNP (70 kDa, A and C), Scl-70, Jo-1 qualitative
100 x 01
IS-AI10021
ChLIA IDS ANA Screen Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-AI10301
ChLIA IDS dsDNA IgG antigenic coated magnetic particles dsDNA quantitative
100 x 01
IS-AI11011
ChLIA IDS SS-A/Ro antigenic coated magnetic particles SS-A/Ro quantitative
50 x 01
IS-AI11021
ChLIA IDS SS-A/Ro 60 kDa antigenic coated magnetic particles SS-A/Ro 60 kDa quantitative
50 x 01
IS-AI11041
ChLIA IDS SS-B/La antigenic coated magnetic particles SS-B/La quantitative
50 x 01
IS-AI11051
ChLIA IDS Sm antigenic coated magnetic particles Sm quantitative
50 x 01
IS-AI11061
ChLIA IDS U1-snRNP antigenic coated magnetic particles U1-snRNP (70 kDa, A, C) quantitative
50 x 01
IS-AI11071
ChLIA IDS ANA Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-AI11301
ELISA Anti-ribosomal P Proteins ELISA (IgG) antigen-coated
microplate wells
native, P0/P1/P2 of the 60S ribosomal
subunit, calf thymus
2/20/200 RU/ml IgG 96 x 01
EA 1641-9601 G
ChLIA Nu.Q® NETs
H3.1 nucleosome
Antibody-coated magnetic particles H3.1 nucleosome quantitative
100 x 01
2001-02-011
IIFT dsDNA (sensitive) EUROPattern flagellates
(1 BIOCHIP per field)
Crithidia luciliae IgG
IgG
IgG
IgG
24 x 50
120 x 10
20 x 05
20 x 10

FC 1572-12010-1-R
FC 1572-2005-1-R
FC 1572-2010-1-R
IIFT dsDNA (sensitive) flagellates
(1 BIOCHIP per field)
Crithidia luciliae IgG
IgG
20 x 05
20 x 10
FA 1572-2005-1-R
FA 1572-2010-1-R
IIFT dsDNA flagellates
(1 BIOCHIP per field)
Crithidia luciliae IgG
IgG
20 x 05
20 x 10
FA 1572-2005-R
FA 1572-2010-R
IIFT dsDNA EUROPattern flagellates
(1 BIOCHIP per field)
Crithidia luciliae IgG
IgG
20 x 05
20 x 10
FC 1572-2005-R
FC 1572-2010-R
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC.
1 Product manufactured by third party. Please contact your local Euroimmun representative for more information.